Impact of blood transfusions on survival and recurrence in colorectal cancer surgery
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F13%3AE0103698" target="_blank" >RIV/00843989:_____/13:E0103698 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/61988987:17110/13:A14019WH
Výsledek na webu
<a href="http://dx.doi.org/10.1007/s12262-012-0427-6" target="_blank" >http://dx.doi.org/10.1007/s12262-012-0427-6</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s12262-012-0427-6" target="_blank" >10.1007/s12262-012-0427-6</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Impact of blood transfusions on survival and recurrence in colorectal cancer surgery
Popis výsledku v původním jazyce
The aim of our study was to evaluate the prognostic significance of blood transfusion on recurrence and survival in patients undergoing curative resections for colorectal cancer. Retrospective analysis of prospectively collected data of patients after elective resections for colorectal cancer between January 2001 and December 2009 was undertaken. The main endpoint was overall survival, disease-free survival, and recurrence rate. These data were evaluated in relation to blood transfusion (group A, no blood transfusion; group B, one to two blood transfusions; group C, three and more blood transfusions). A total of 583 patients met the criteria for inclusion in the study. Of these, 132 (22.6 %) patients received blood transfusion in the perioperative period. There were 83 (14.2 %) patients who received one or two blood transfusions and 49 (8.4 %) patients who required three or more transfusions. Patients with three or more transfusions had a significantly worse 5-year overall survival, di
Název v anglickém jazyce
Impact of blood transfusions on survival and recurrence in colorectal cancer surgery
Popis výsledku anglicky
The aim of our study was to evaluate the prognostic significance of blood transfusion on recurrence and survival in patients undergoing curative resections for colorectal cancer. Retrospective analysis of prospectively collected data of patients after elective resections for colorectal cancer between January 2001 and December 2009 was undertaken. The main endpoint was overall survival, disease-free survival, and recurrence rate. These data were evaluated in relation to blood transfusion (group A, no blood transfusion; group B, one to two blood transfusions; group C, three and more blood transfusions). A total of 583 patients met the criteria for inclusion in the study. Of these, 132 (22.6 %) patients received blood transfusion in the perioperative period. There were 83 (14.2 %) patients who received one or two blood transfusions and 49 (8.4 %) patients who required three or more transfusions. Patients with three or more transfusions had a significantly worse 5-year overall survival, di
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FJ - Chirurgie včetně transplantologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2013
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Indian journal of surgery
ISSN
0972-2068
e-ISSN
—
Svazek periodika
75
Číslo periodika v rámci svazku
n. 2
Stát vydavatele periodika
IN - Indická republika
Počet stran výsledku
8
Strana od-do
"p. 94-101"
Kód UT WoS článku
000318705900004
EID výsledku v databázi Scopus
—